Sodium Phenylacetate And Sodium Benzoate Injection, Solution, Concentrate
Product Images NDC 81665-203

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sodium Phenylacetate And Sodium Benzoate (NDC 81665-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Omnivium Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ammonul 01)

FDA Label Image

Figure 2 (Ammonul 02)

FDA Label Image

Principal Display Panel (50 mL Vial Carton)

Principal Display Panel (50 mL Vial Carton)
This is a description of a medication labeled as Sodium Phenylacetate and Sodium Benzoate Injection, with a concentration of 10% / 10%. The medication is for intravenous use only and comes in a 50mL vial. The storage conditions recommended are between 15°C - 30°C (59°F - 86°F). It is important to dilute the concentrated solution before intravenous administration to prevent burns as it may cause irritation. Each vial contains a mixture of 100 mg of sodium phenylacetate and 100 mg of sodium benzoate along with water and hydrochloric acid. It is a sterile, non-pyrogenic, single-dose vial.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.